Jump to content

Molecular Computing Patent Application Trends 2025: Difference between revisions

From WikiPatents
Updating Molecular Computing Patent Application Trends 2025
Updating Molecular Computing Patent Application Trends 2025
 
Line 1: Line 1:
== Molecular Computing Patent Application Filing Activity ==
== Molecular Computing Patent Application Filing Activity ==
== Molecular Computing patent applications in 2025 ==
== Molecular Computing patent applications in 2025 ==
[[File:Molecular_Computing_Monthly_Patent_Applications_2025_-_Up_to_April 2025.png|border|800px]]
[[File:Molecular_Computing_Monthly_Patent_Applications_2025_-_Up_to_May 2025.png|border|800px]]


== Top Technology Areas in Molecular Computing ==
== Top Technology Areas in Molecular Computing ==
[[File:Top_Technology_Areas_in_Molecular_Computing_2025_-_Up_to_April 2025.png|border|800px]]
[[File:Top_Technology_Areas_in_Molecular_Computing_2025_-_Up_to_May 2025.png|border|800px]]


=== Top CPC Codes ===
=== Top CPC Codes ===
Line 12: Line 12:
* [[:Category:CPC_A61K39/4631|A61K39/4631]] ({Cellular immunotherapy})
* [[:Category:CPC_A61K39/4631|A61K39/4631]] ({Cellular immunotherapy})
** Count: 5 patents
** Count: 5 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_A61P35/00|A61P35/00]] (Antineoplastic agents)
** Count: 4 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_C07K14/7051|C07K14/7051]] (PEPTIDES  (peptides in foodstuffs)
* [[:Category:CPC_C07K14/7051|C07K14/7051]] (PEPTIDES  (peptides in foodstuffs)
** Count: 3 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_A61P35/00|A61P35/00]] (Antineoplastic agents)
** Count: 3 patents
** Count: 3 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
Line 23: Line 23:
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_A61K2239/38|A61K2239/38]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
* [[:Category:CPC_A61K2239/38|A61K2239/38]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
** Count: 2 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_A61K2239/47|A61K2239/47]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
** Count: 2 patents
** Count: 2 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
Line 32: Line 35:
** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]]
** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]]
* [[:Category:CPC_C07K2319/02|C07K2319/02]] (PEPTIDES  (peptides in foodstuffs)
* [[:Category:CPC_C07K2319/02|C07K2319/02]] (PEPTIDES  (peptides in foodstuffs)
** Count: 2 patents
** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]]
* [[:Category:CPC_C07K2319/03|C07K2319/03]] (PEPTIDES  (peptides in foodstuffs)
** Count: 2 patents
** Count: 2 patents
** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]]
** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]]
Line 90: Line 90:
* Recent patents:
* Recent patents:
** [[20250135016. MOLECULAR LOGIC GATES FOR CONTROLLED MATERIAL DEGRADATION (University of Washington)]] (20250501)
** [[20250135016. MOLECULAR LOGIC GATES FOR CONTROLLED MATERIAL DEGRADATION (University of Washington)]] (20250501)
=== [[:Category:University of Florida Research Foundation, Incorporated|University of Florida Research Foundation, Incorporated]] ===
* Number of Molecular Computing patents: 1
* Top CPC codes:
** [[:Category:CPC_A61K40/429|A61K40/429]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
** [[:Category:CPC_A61K35/17|A61K35/17]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
** [[:Category:CPC_A61K40/11|A61K40/11]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
* Recent patents:
** [[20250170242. CHIMERIC LACTATE RECEPTOR ENGINEERED T CELLS (University of Florida Research Foundation, Incorporated)]] (20250529)
=== [[:Category:PRECIGEN, INC.|PRECIGEN, INC.]] ===
=== [[:Category:PRECIGEN, INC.|PRECIGEN, INC.]] ===
* Number of Molecular Computing patents: 1
* Number of Molecular Computing patents: 1
Line 123: Line 131:


* [[:Category:CPC_C12N2740/15041|C12N2740/15041]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media)
* [[:Category:CPC_C12N2740/15041|C12N2740/15041]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media)
** Count: 1 patents
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
* [[:Category:CPC_A61K2239/22|A61K2239/22]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
Line 141: Line 146:
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
* [[:Category:CPC_C07K16/28|C07K16/28]] (PEPTIDES  (peptides in foodstuffs)
* [[:Category:CPC_C07K16/28|C07K16/28]] (PEPTIDES  (peptides in foodstuffs)
** Count: 1 patents
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
* [[:Category:CPC_A61K35/17|A61K35/17]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
Line 152: Line 154:
** Count: 1 patents
** Count: 1 patents
** Example: [[20250085924. METHOD FOR MOLECULAR COMPUTING (DNA 2 Ascendancy AB)]]
** Example: [[20250085924. METHOD FOR MOLECULAR COMPUTING (DNA 2 Ascendancy AB)]]
* [[:Category:CPC_G01N33/6845|G01N33/6845]] ({Methods of identifying protein-protein interactions in protein mixtures})
** Count: 1 patents
** Example: [[20250084406. REVERSIBLE HETERODIMERIZING SYSTEMS AS EFFECTORS FOR FEEDBACK CONTROL (The Regents of the University of California)]]
* [[:Category:CPC_C12N15/1055|C12N15/1055]] ({Protein x Protein interaction, e.g. two hybrid selection})
** Count: 1 patents
** Example: [[20250084406. REVERSIBLE HETERODIMERIZING SYSTEMS AS EFFECTORS FOR FEEDBACK CONTROL (The Regents of the University of California)]]


== Top Companies in Emerging Molecular Computing Technologies 2025==
== Top Companies in Emerging Molecular Computing Technologies 2025==
[[File:Top_Companies_in_Emerging_Molecular_Computing_Technologies.png|border|800px]]
[[File:Top_Companies_in_Emerging_Molecular_Computing_Technologies.png|border|800px]]


* [[:Category:INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.]]: 8 patents
* [[:Category:INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.]]: 6 patents
* [[:Category:The Regents of the University of California|The Regents of the University of California]]: 2 patents
* [[:Category:DNA 2 Ascendancy AB|DNA 2 Ascendancy AB]]: 2 patents
* [[:Category:DNA 2 Ascendancy AB|DNA 2 Ascendancy AB]]: 2 patents


Line 352: Line 361:
* Recent patents:
* Recent patents:
** [[20250135016. MOLECULAR LOGIC GATES FOR CONTROLLED MATERIAL DEGRADATION (University of Washington)]] (20250501)
** [[20250135016. MOLECULAR LOGIC GATES FOR CONTROLLED MATERIAL DEGRADATION (University of Washington)]] (20250501)
=== [[:Category:Loic Deleyrolle|Loic Deleyrolle of Gainesville FL (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:University of Florida Research Foundation, Incorporated|University of Florida Research Foundation, Incorporated]]: 1 patents
* Recent patents:
** [[20250170242. CHIMERIC LACTATE RECEPTOR ENGINEERED T CELLS (University of Florida Research Foundation, Incorporated)]] (20250529)
=== [[:Category:Duane Mitchell|Duane Mitchell of Gainesville FL (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:University of Florida Research Foundation, Incorporated|University of Florida Research Foundation, Incorporated]]: 1 patents
* Recent patents:
** [[20250170242. CHIMERIC LACTATE RECEPTOR ENGINEERED T CELLS (University of Florida Research Foundation, Incorporated)]] (20250529)
=== [[:Category:Jianping Huang|Jianping Huang of Gainesville FL (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:University of Florida Research Foundation, Incorporated|University of Florida Research Foundation, Incorporated]]: 1 patents
* Recent patents:
** [[20250170242. CHIMERIC LACTATE RECEPTOR ENGINEERED T CELLS (University of Florida Research Foundation, Incorporated)]] (20250529)
=== [[:Category:Linchun Jin|Linchun Jin of Gainesville FL (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:University of Florida Research Foundation, Incorporated|University of Florida Research Foundation, Incorporated]]: 1 patents
* Recent patents:
** [[20250170242. CHIMERIC LACTATE RECEPTOR ENGINEERED T CELLS (University of Florida Research Foundation, Incorporated)]] (20250529)
=== [[:Category:Mark Anton HELD|Mark Anton HELD of Germantown MD (US)]] ===
=== [[:Category:Mark Anton HELD|Mark Anton HELD of Germantown MD (US)]] ===
* Number of Molecular Computing patents: 1
* Number of Molecular Computing patents: 1
Line 458: Line 491:
* ZΓΌrich-Schlieren: 5 inventors
* ZΓΌrich-Schlieren: 5 inventors
* Boston: 4 inventors
* Boston: 4 inventors
* Gainesville: 4 inventors
* Seattle: 2 inventors
* Seattle: 2 inventors
* Palo Alto: 1 inventors
* Palo Alto: 1 inventors

Latest revision as of 05:42, 4 June 2025

Molecular Computing Patent Application Filing Activity

Molecular Computing patent applications in 2025

Top Technology Areas in Molecular Computing

Top CPC Codes

Top Companies in Molecular Computing 2025

File:Top Companies in Molecular Computing.png

The Regents of the University of California

INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.

Molecular Partners AG

CZ Biohub SF, LLC

THE GENERAL HOSPITAL CORPORATION

University of Washington

University of Florida Research Foundation, Incorporated

  • Number of Molecular Computing patents: 1
  • Top CPC codes:
    • A61K40/429 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
    • A61K35/17 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
    • A61K40/11 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
  • Recent patents:

PRECIGEN, INC.

DNA 2 Ascendancy AB

INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.

New Companies in Molecular Computing (Last Month)

File:New Companies in Molecular Computing Last Month.png

No new companies detected in the last month.

Emerging Technology Areas in Molecular Computing

Top Companies in Emerging Molecular Computing Technologies 2025

Top Inventors in Molecular Computing

Wei XU

Huafeng WEI

Wendell A. Lim of San Francisco CA (US)

Hideho Okada of San Francisco CA (US)

Kole T. Roybal of San Francisco CA (US)

Joseph H. Choe of San Francisco CA (US)

Payal B. Watchmaker of San Francisco CA (US)

James A. WELLS of San Francisco CA (US)

Zachary B. HILL of San Francisco CA (US)

Alexander J. MARTINKO of San Francisco CA (US)

Diana Binia DAROWSKI

Dan XU

Ying YAO

Bianka PRINZ

Nadthakarn BOLAND

James GEOGHEGAN

Simon Fontaine

Andreas Bosshart

Bernd Schlereth

Daniel Steiner

Marcel Walser

Hyongsok Soh of Palo Alto CA (US)

Alexander M. Yoshikawa of Redwood City CA (US)

Alexandra E. Rangel of Santa Clara CA (US)

Amani Hariri of Stanford CA (US)

Max Jan of Boston MA (US)

Quinlan L. Sievers of Boston MA (US)

Benjamin Ebert of Boston MA (US)

Marcela Maus of Boston MA (US)

Cole DeForest of Seattle WA (US)

Barry Badeau of Seattle WA (US)

Loic Deleyrolle of Gainesville FL (US)

Duane Mitchell of Gainesville FL (US)

Jianping Huang of Gainesville FL (US)

Linchun Jin of Gainesville FL (US)

Mark Anton HELD of Germantown MD (US)

Xinhua ZHAO of Germantown MD (US)

Lily Yuin CHAO of Germantown MD (US)

Na TRINH of Germantown MD (US)

James KEALEY of Germantown MD (US)

Kevin Lee DIETZEL of Germantown MD (US)

Taylor Hanh NGUYEN of San Francisco CA (US)

Galen DODS of San Francisco CA (US)

Hana EL-SAMAD of San Francisco CA (US)

Andrew H. NG of San Francisco CA (US)

Ross D. KING

Konstantin KOROVIN

Shengjie GUO

Jianan CHEN

Guozhi CHEN

Top Collaborations in Molecular Computing

Top US States for Molecular Computing Inventors


Top Cities for Molecular Computing Inventors

  • Suzhou, Jiangsu: 13 inventors
  • San Francisco: 12 inventors
  • Germantown: 6 inventors
  • ZΓΌrich-Schlieren: 5 inventors
  • Boston: 4 inventors
  • Gainesville: 4 inventors
  • Seattle: 2 inventors
  • Palo Alto: 1 inventors
  • Redwood City: 1 inventors
  • Santa Clara: 1 inventors
  • Stanford: 1 inventors
  • Borth: 1 inventors
  • Huddersfield: 1 inventors
Cookies help us deliver our services. By using our services, you agree to our use of cookies.